Rutgers and Tel Aviv Universities Joint Scientific Symposia Series: Exploring Drug Discovery

Join leading experts from Rutgers and Tel Aviv Universities as they explore the topic of drug discovery.

• Protein Data Bank: Impact on Drug Discovery and Early Drug Development; Presented by Stephen Burley, MD, DPhil, Rutgers University

Stephen Kevin Burley is an expert in structural biology, biophysics, computational biology, data science, structure/fragment-based drug discovery, and clinical medicine/oncology. Burley is the director of the RCSB Protein Data Bank (rcsb.org). Within Rutgers, he serves as University Professor and Henry Rutgers Chair, founding director of the Institute for Quantitative Biomedicine, and a member of the Rutgers Cancer Institute of New Jersey, where he co-leads the Cancer Pharmacology Research Program.

• Turning Multidisciplinary Science into Therapeutic Leads; Presented by Ehud Gazit, PhD, FRSC, FNASc OSSI, Tel Aviv University

Ehud Gazit is a professor and Endowed Chair at the School of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences and the Department of Materials Science and Engineering, Faculty of Engineering and a member of the Executive Council of Tel Aviv University. He is also a member of Israel National Council for Research and Development. Gazit is also the founding director of the BLAVATNIK CENTER for Drug Development and the Head of the Laura Schwartz-Kipp Institute for Biotechnology.

Presentations will be followed by a Q&A session moderated by Vince Smeraglia, Executive Director of Strategic Alliances, Office for Research, Rutgers University

Symposia series hosted by: